Welcome to the United Kingdom Metaplastic Breast Cancer Community
Welcome to the United Kingdom
The United Kingdom of Great Britain and Northern Ireland, known as the UK, is composed of four separate countries: England, Scotland, Wales and Northern Ireland. The UK is a constitutional monarchy, Queen Elizabeth 11 is the current monarch and has reigned since 1952. You may find Welsh spoken in Wales; Gaelic in parts of Scotland and Northern Ireland and even Cornish in Cornwall all of these being a Celtic language but English is the main spoken language. London is the capital of the UK.
The more we engage globally the more we prosper.
United Kingdom Metaplastic Breast Cancer Global Representatives
Contacts: email admin@mpbcalliance.org
United Kingdom Healthcare
The National Health Service (NHS) was launched In Manchester, England in 1948. Then, for the first time, hospitals, doctors, nurses, pharmacists, opticians and dentists were brought together to provide services for free at the point of delivery. There have been a number of reorganisations over the years but the provision of services remains free. Funding for the NHS comes directly from taxation.
One of the core principles of the NHS is that good healthcare should be available to all, regardless of wealth. The exceptions are some charges, such as prescriptions, optical services and dental services.
Organisationally the NHS provision in the UK is managed regionally as: NHS England, NHS Northern Ireland, NHS Scotland and NHS Wales. The provision of services remains free at the point of use for all UK residents. This currently stands at more than 64.6 million people in the UK and 54.3 million people in England alone.
The National Institute for Health and Care Excellence (NICE) produces guidance (advice) for the NHS about preventing, diagnosing and treating medical conditions. The guidance is written by independent experts, including healthcare professionals and people representing patients and carers. They consider the evidence on the disease and treatments, the views of patients and carers and the experiences of doctors, nurses and other healthcare professionals, and consider the costs involved.
Staff working in the NHS are expected to follow this guidance. For a rare cancer like Metaplastic Breast Cancer this might create problems in terms of choosing treatment options as NICE does not separate MbBC from Triple Negative Breast Cancer.
Knowledgeable Doctors: Researchers
For more information on individual knowledgeable doctors listed below, please click the link for the website
associated with the knowledgeable doctor you are interested in learning more about.
| Name | Address | Location | Phone Number | Website | Researching |
|---|---|---|---|---|---|
| Ciara O’Brien | Consultant and Honorary Senior Lecturer in Medical Oncology The Christie NHS Foundation Trust Wilmslow Road Manchester M20 4BX United Kingdom |
United Kingdom | 0161 446 3746 | HERE | Molecular target discovery in breast cancer Data mining (big data) projects in breast oncology Clinical trials of new agents for breast cancer Publications/Researching |
- Clinical Trials & Researchers
- Helpful information / Links
- Financial Resources
- Facebook Treatment Support Groups
- Glossary of Terms
- Breast Cancer Oncology Acronyms
- Detailed Introduction to MpBC
- Rare Cancers UK
- MpBC Current Understandings & Future Directions
- Common MpBC Genetic Mutations – ESMO 2024
- The BRCAs – NHS Foundation Trust, Corso et al
- Treatment (non metastatic, same as TNBC patients)
- https://www.macmillan.org.uk/cancer-information-and-support/breast-cancer/triple-negative-breast-cancer
- Keytruda / High Risk TNBC – NHS
- Neulasta/LaPelga (pegfilgrastim) Info & Tips- Canada
- Chemo Side Effects
- Precision Oncology – ESMO
- Complimentary Therapies
- DPD Deficiency (taking Xeloda or Fluorouracil info)
- Hope and Hype (several Trials) – Brussels
- MpBC vs IDC Study / Sungkyunkwan University, Korea
- The Metaplastic Conundrum/ NCI – Egypt
- Neoadjuvant therapy TN MpBC- Xi’an Jiaotong Univ.
- Lymph nodes metastasis study – China
- 2412 MpBC Patient Lumpectomy Study – China
- MpBC Outcomes (Review by Subtype) 2023
- Survival Rates (pre Keynote) – St. Gallen, Switzerland
- PCR Rate Study – Yam C et al, Samsung Medical Center
- Living with Breast Cancer
- MpBC Follow Up Care
Experienced UK MpBC Oncologists
- https://futuredreams.org.uk/breast-cancer-financial-aid/
- https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/benefits-and-financial-support
- https://www.cancerresearchuk.org/about-cancer/coping/practically/financial-suppor
- https://www.maggies.org/cancer-support/managing-practically/money-benefits-and-cancer/
- UK Womens Brest Cancer Support Group
- UK Breast Cancer- TNBC Specific
- Metaplastic Breast Cancer Global Alliance
- Immunotherapy/ Keytruda Support Group
- Adrenal Insufficiency United (immunotherapy related)
- For ladies with Adrenal Insufficiency ONLY
- Troldevy Stage -4 Support Group
- Xeloda (Capecitabine) Support Group
- Lynparza Support Group
- TNBC Stage 4 Women’s Only Group
The MpBC Global Alliance, Inc. is dedicating the UK Community Page in honor of Sue McCaldon’s efforts and support to help advance global research into Metaplastic Breast Cancer.
